Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -4.85% 49.00 48.00 50.00 51.50 48.50 51.50 601,391 14:00:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.5 -1.9 -2.3 - 42

OptiBiotix Health PLC Director's Dealing

28/08/2019 10:00am

UK Regulatory (RNS & others)


Optibiotix Health (LSE:OPTI)
Historical Stock Chart

3 Months : From Aug 2019 to Nov 2019

Click Here for more Optibiotix Health Charts.

TIDMOPTI

RNS Number : 3997K

OptiBiotix Health PLC

28 August 2019

28 August 2019

OptiBiotix Health plc

("OptiBiotix" or the "Company")

Director's Dealing

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it received notification today that Frédéric Narbel, a Director of the Company, acquired 17,000 ordinary shares in the Company today, representing 0.02% of the Company's issued share capital, at a price of 50 pence per share.

Following the transaction, Mr Narbel is interested in 29,000 ordinary shares in the Company, representing 0.03% of the Company's issued share capital.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 and the person who arranged for release of this announcement on behalf of the Company was Stephen O'Hara, Chief Executive.

For further information, please contact:

 
 OptiBiotix Health plc                                  www.optibiotix.com 
 Stephen O'Hara, Chief Executive                      Contact via Walbrook 
                                                                     below 
 
 Cairn Financial Advisers LLP (NOMAD)                   Tel: 020 7213 0880 
 Liam Murray / Jo Turner / Ludovico Lazzaretti 
 
 finnCap (Broker)                                       Tel: 020 7220 0500 
 Geoff Nash / Kate Bannatyne (Corporate Finance) 
 Camille Gochez (Corporate Broking) 
 
 goetzpartners securities Limited                       Tel: 0203 859 7725 
 Ulrich Kinzel 
 
 Walbrook PR Ltd                                        Mob: 07876 741 001 
 Anna Dunphy 
 
 

About OptiBiotix - www.optibiotix.com

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D program working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.

 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
        ----------------------------------------------------------------------------------------- 
 a.      Name                                     Frédéric André Narbel 
        ---------------------------------------  ------------------------------------------------ 
 2       Reason for notification 
        ---------------------------------------  ------------------------------------------------ 
 a.      Position/Status                          Director of the Company 
        ---------------------------------------  ------------------------------------------------ 
 b.      Initial notification/                    Initial Notification 
          Amendment 
        ---------------------------------------  ------------------------------------------------ 
 3       Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
        ----------------------------------------------------------------------------------------- 
 a.      Name                                     OptiBiotix Health Plc 
        ---------------------------------------  ------------------------------------------------ 
 b.      LEI                                      213800UKYQFT941QHS14 
        ---------------------------------------  ------------------------------------------------ 
 4       Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
        ----------------------------------------------------------------------------------------- 
 a.      Description of                           17,000 ordinary shares of 2p each 
          the financial 
          instrument, type 
          of instrument 
                                                   ISIN: GB00BP0RTP38 
          Identification 
          Code 
        ---------------------------------------  ------------------------------------------------ 
 b.      Nature of the                            Purchase of 17,000 ordinary shares in the 
          transaction                              Company 
        ---------------------------------------  ------------------------------------------------ 
 
 c.      Price(s) and volume(s)                    Price(s) per               Volume(s) 
                                                    share 
        ---------------------------------------   ------------------------- 
                                                   50p                        17,000 
                                                  -------------------------  ----------------- 
 
 e.      Date of the transaction                  28 August 2019 
        ---------------------------------------  ------------------------------------------------ 
 f.      Place of the transaction                 London Stock Exchange, AIM 
        ---------------------------------------  ------------------------------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGIGDIISDBGCI

(END) Dow Jones Newswires

August 28, 2019 05:00 ET (09:00 GMT)

1 Year Optibiotix Health Chart

1 Year Optibiotix Health Chart

1 Month Optibiotix Health Chart

1 Month Optibiotix Health Chart
Your Recent History
LSE
OPTI
Optibiotix..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191121 06:49:34